Emilie Rodrigues

Emilie Rodrigues has a diverse work experience spanning various roles and companies.

Emilie started their career as a Research Engineer at the Department of Developmental BioEngineering - MIRA Institute, University of Twente in 2008. Emilie then pursued a PhD in Tissue Engineering at the same institute, which they completed in 2012.

In 2013, they worked as a Process Engineer at CB&I. Emilie subsequently joined Intravacc in 2014 as a Process Engineer. During their time there, they also held the roles of Team Supervisor and Project Lead. Their tenure at Intravacc lasted until December 2021.

In early 2022, Emilie Rodrigues joined Synerkine Pharma as the Director of CMC Development. Their current role implies that they are responsible for overseeing the development of the company's chemistry, manufacturing, and control processes.

Overall, Emilie Rodrigues has developed a strong background in process engineering, with a focus on tissue engineering and pharmaceutical development.

Emilie Rodrigues obtained a Master's degree in Chemical Engineering from the University of Lisbon in 2008. Afterwards, they pursued a Doctor of Philosophy (PhD) in Tissue Engineering at the University of Twente, from 2008 to 2012. Additional information regarding their education history, such as any studies at the University of Minnesota, is not provided.